Japan's Kyushu University signs strategic partnership agreement with GSK

GlaxoSmithKline K.K. and National University Corporation Kyushu University have signed a strategic partnership agreement...

October 9, 2023 | Monday | News
First-of-its-kind partnership in Singapore to advance drug discovery

Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, and the Polaris Innovation Fund, along with global li...

October 6, 2023 | Friday | News
Leveraging data intelligence for precision drug development

The life sciences industry is entering a digital renaissance. Organizations are increasingly exploring and investing in ...

September 29, 2023 | Friday | Opinion
Japan's PeptiDream inks $40 M deal with Genentech for novel peptide-radioisotope drug conjugates

PeptiDream Inc., a Japan-based biopharmaceutical company, has announced a new multi-target collaboration and license agr...

September 20, 2023 | Wednesday | News
Korea-US partnership to revolutionise AI-based early drug discovery

South Korea-based startup Standigm, a company using artificial intelligence (AI) technology for drug discovery and devel...

August 16, 2023 | Wednesday | News
Japan-based Chugai Pharma and Omron focus on automation for drug discovery research

Japanese firms Chugai Pharmaceutical Co., and Omron Corporation are working together on the automation of research proce...

July 17, 2023 | Monday | News
AI & Biotech- Transforming each other!

Rapid developments are taking place across the fields of artificial intelligence (AI) and biotechnology, and application...

July 5, 2023 | Wednesday | Analysis
University of Sydney inks MoU with Pharos Therapeutics for AI-based drug discovery

The University of Sydney, Australia has signed a Memorandum of Understanding (MoU) with Pharos Therapeutics, the Austral...

May 31, 2023 | Wednesday | News
Korea-US partnership to co-develop therapy for Parkinson's Disease

South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...

May 26, 2023 | Friday | News
Japan govt injects $200M to support third phase operations of GHIT Fund

Prime Minister Fumio Kishida has recently announced the Government of Japan's pledge to contribute&n...

May 26, 2023 | Friday | News
Korean firm Avixgen to expedite drug pipeline development and pursue IPO in 2025

South Korea-based Avixgen is currently having a strong pipeline in ophthalmic diseases such as age related macular degen...

May 25, 2023 | Thursday | News
Biodrug Design Accelerator platform launches in Japan to accelerate peptide drug discovery research

Japanese firm Fujitsu has announced the commercial debut of its "Biodrug Design Accelerator," a platform to manage resea...

May 18, 2023 | Thursday | News
Japan's Otsuka Pharma gets US FDA nod for drug to treat agitation during Alzheimer's

The US Food and Drug Administration (FDA) has announced the supplemental approval of Rexulti (brexpiprazole) o...

May 12, 2023 | Friday | News
Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...

May 8, 2023 | Monday | News
Korea's Daewoong Pharma inks $477 M deal with US partner for autoimmune disease treatment

South Korea-based Daewoong Pharmaceutical has signed a Global License Agreement for its autoimmune disease drug can...

April 28, 2023 | Friday | News
New drug discovery research collaboration between Korea & UK

South Korean firm Daewoong Pharmaceutical has entered a research collaboration with UK-based Sygnature Discovery to expa...

April 19, 2023 | Wednesday | News
Eisai invests ¥ 8.5 B to revamp Tsukuba Research Laboratories in Japan

Japanese pharmaceutical firm Eisai Co. has announced the completion of a major renovation of its Tsukuba Research Labora...

April 8, 2023 | Saturday | News
Japanese firm Takeda Pharma inks $415 M deal for celiac disease research

French firm Innate Pharma has entered into an exclusive license agreement with Japanese pharmaceutical company Takeda un...

April 3, 2023 | Monday | News